Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

How is the Smart Money Playing Mega-Dividend Stocks? – Merck & Co., Inc. (MRK), Intel Corporation (INTC), Verizon Communications Inc. (VZ)

Page 1 of 2

Only 47 stocks in the S&P 500 currently pay a dividend yield in excess of four percentage points, and of this top decile, a little over half sport market capitalizations greater than $10 billion. This pool includes companies of all walks of life, from tech to utilities. The smart money is heavily invested in this space, and the 400-plus top-tier hedge funds we track have over $19 billion invested in the so-called “mega-dividend” club.

While the hedge fund industry as a whole has disappointed of late, we at Insider Monkey have proven that the best money managers—the Buffetts and the Einhorns, if you will—can beat the market consistently (here’s how they do it). The performance of the MarketWatch Insider Monkey Billionaire Hedge Fund Index, which outpaced the S&P 500 ETF by 8% last year, also supports this notion.

With this in mind, let’s take a look at the mega-dividend payers that have the greatest support from the smart money.

Merck & Co., Inc. (NYSE:MRK)

Merck & Co., Inc. (NYSE:MRK) is far and away hedge funds’ top pick of this group. At the end of the last full 13F filing period with the SEC, 53 funds held bullish positions in the global pharma giant, including Stanley Druckenmiller, Cliff Asness and Joel Greenblatt. Merck currently pays a dividend yield of 4.1%, and shares have risen by more than 9% over the past 12 months.

The company was a winner in its latest earnings report, though some investors have been turned off by its decision to delay filing for FDA approval of its osteoporosis drug Odanacatib until 2014. Still, at 10.9 times forward earnings, Merck trades at a discount to Pfizer and Johnson & Johnson.

Next up we have Intel Corporation (NASDAQ:INTC), which has support from 44 of the 400 or so hedge funds we track. With a dividend payout yielding more than 4.2%, Intel is in rare territory as a tech stock. It’s one of only five large-cap companies in this sector to yield above this mark, and it is the best value of the bunch at a PEG ratio of 0.84. Value and income-oriented investors can both take solace in the fact that Ken Fisher (see his full portfolio) and Jim Simons are two of Intel’s biggest bulls.

Verizon Communications Inc. (NYSE:VZ) sits at third among hedge funds’ favorite mega-dividend stocks. One would naturally be inclined to think that because Verizon pays a dividend yield of 4.6%—far greater than Merck and Intel—hedgies would prefer the telecom company, aggregately speaking. With 39 funds invested, though, this is obviously not the case. One look at Verizon’s earnings history may explain why; it has missed Wall Street’s EPS estimates in two of the past five quarters, while experiencing a positive surprise just once over this time.

Still, the telecom’s 4G LTE system offers dominant nationwide coverage over AT&T, and shares of Verizon trade at a 30% discount to their key competitor on a price-to-sales basis.

Who’s the best of the rest?

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!